Investors eager to do some heavy lifting for Malin shares

Drug and biotech fund Malin is thought to have buyers waiting in the wings to snap up a huge block of shares in the company held by embattled fund manager Neil Woodford.

It is understood that institutional and individual investors are keen to lift the overhang on Malin’s share price caused by Woodford’s 23 per cent holding in the company by acquiring the stock. Approaches to him are thought to have been made.